Incidence of Emergence Delirium in the PACU
PACUDEL
1 other identifier
observational
1,421
1 country
1
Brief Summary
Emergence delirium (ED) is serious complication in the postoperative period in paediatric anaesthesia, reported incidence is 20-60%. It is characterized by psychomotor and perception disorder with excitation of paediatric patients. Emergence delirium has impact on morbidity and even on mortality of paediatric patients in the postoperative period. The potential risk factors for ED development include sevoflurane, which is the dominant anaesthetic agent used in the paediatric patients, and which is actually the only inhalation agent used for inhalation anaesthesia induction. The incidence of ED is higher in postoperative period, for example in the Post-anaesthesia Care Unit - PACU. Patients with ED are at higher risk of psychomotor anxiety, agitation, unintentional extraction of intravenous cannula, and nausea and vomiting. For the therapy of ED propofol, midazolam and eventually ketamine in a reduced dosage are used.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Oct 2020
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 21, 2020
CompletedFirst Posted
Study publicly available on registry
August 28, 2020
CompletedStudy Start
First participant enrolled
October 1, 2020
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 30, 2021
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2022
CompletedFebruary 15, 2022
February 1, 2022
9 months
August 21, 2020
February 14, 2022
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The incidence of emergence delirium
The incidence of emergence delirium, defined as PAED score above 10 points and/or WATCHA score over 2 and or RASS over 1 minimally in one of the measurements. All measurements will be measured in 0., 5., 10., 15., and 20. minute after PACU admission. The first measurement (T0) will be intiated after first obtaining RASS over -2.
up to 60 minutes after PACU admission
Secondary Outcomes (11)
The duration of ED
up to 60 minutes after PACU admission
The average PAED score
up to 60 minutes after PACU admission
The need for pharmacology intervention incidence
up to 60 minutes after PACU admission
incidence of postoperative nausea and vomiting (PONV)
up to 60 minutes after PACU admission
type of anaesthesia induction (inhalation vs. intravenous)
up to 60 minutes after PACU admission
- +6 more secondary outcomes
Study Arms (1)
Patients at PACU
Patients undergoing elective surgical or diagnostic intervention admitted to PACU after postanaesthesia recovery
Interventions
The incidence of emergence delirium, defined as PAED score above 10 points minimally in one of the PAED score measurements. PAED score will be measured in 0., 5., 10., 15., and 20. minute after PACU admission.
Eligibility Criteria
Patients after general anaesthesia hospitalized in the PACU
You may qualify if:
- Patients after general anaesthesia hospitalized in the PACU in the term rom 1.9.2020 until 30.6.2021.
You may not qualify if:
- Patients in the age from 0 to 1 month.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Hospital Brno
Brno, Česká Republika, 62500, Czechia
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Petr Štourač, prof. MD., Ph.D.
Faculty of medicince Masaryk University and University Hospital Brno
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Clinical Professor
Study Record Dates
First Submitted
August 21, 2020
First Posted
August 28, 2020
Study Start
October 1, 2020
Primary Completion
June 30, 2021
Study Completion
January 1, 2022
Last Updated
February 15, 2022
Record last verified: 2022-02